ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Immunic Therapeutics
A Senior Medical Director at Immunic AG supports global Phase 3 clinical trials for progressive Multiple Sclerosis, providing medical leadership in study planning, protocol development, regulatory interactions, and safety monitoring.
Headquarters
New York, New York, United States
Company Size
51-200 employees
Founded
2016
Immunic Therapeutics is a late-stage biopharmaceutical company pioneering the development of novel oral therapies for neurologic and autoimmune diseases. Its pipeline includes Vidofludimus Calcium, targeting multiple sclerosis, and IMU-856, targeting celiac disease, among other small-molecule, orally administered candidates. The company is focused on delivering high-quality, oral treatment options with strong efficacy and safety profiles to patients with serious chronic inflammatory and autoimmune diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Immunic Therapeutics.
Medical Director — Multiple Sclerosis
Roche
Global Development Medical Director, Late Respiratory and Immunology Clinical Development
AstraZeneca
Medical Director - Late Phase Research
Florida Cancer Specialists & Research Institute
Medical Director (MD), Multiple Sclerosis
Roche
Medical Director (Contract)
Sitero
Global Development Medical Director
AstraZeneca